A clinical review of the estradiol transdermal patch and gabapentin drug interaction, covering mechanism, sedation risk, CNS overlap, monitoring protocols, and dose-adjustment guidance.
A clinician-level review of the pharmacokinetic and pharmacodynamic interactions between estradiol transdermal patches and SNRIs (venlafaxine, duloxetine), including mechanism, monitoring, dose adjustment, and patient counseling.
A full pharmacological review of the estradiol patch and tadalafil interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling guidance.
A guide to the pharmacodynamic overlap between estradiol transdermal patches and testosterone therapy, including monitoring considerations, dose principles, and where the evidence is solid versus where it is not.
A guide to the estradiol patch and trazodone interaction covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling for safer co-administration.
Can you take Lunesta (eszopiclone) with acetaminophen (Tylenol)? A guide covering the mechanism, evidence status, monitoring, and safe dosing for this drug combination.
A clinician-level review of the eszopiclone, diphenhydramine drug interaction, covering mechanism, severity, dose guidance, monitoring, and patient counseling backed by primary literature.
A guide to the eszopiclone-trazodone drug interaction: mechanism, severity, dose guidance, monitoring, and patient counseling based on FDA labeling and primary literature.
A clinician-level review of the evolocumab (Repatha) and estradiol HRT interaction, covering mechanism, VTE risk, lipid effects, monitoring protocols, and patient counseling guidance.
A detailed clinical review of the evolocumab (Repatha) and progesterone HRT interaction, covering mechanism, DDI severity, monitoring parameters, dose adjustment, and patient counseling backed by primary literature.
A guide to the evolocumab (Repatha) and NSAID interaction, covering pharmacology, cardiovascular and renal risks, monitoring parameters, and practical patient counseling.
A comprehensive clinical guide to the ezetimibe and estradiol HRT interaction, covering mechanism, VTE and breast-cancer risk overlap, monitoring parameters, and patient counseling, prepared by the HealthRX.com Editorial Team.
A comprehensive guide to the ezetimibe, tadalafil drug interaction, covering mechanism, safety evidence, monitoring, and dosing guidance.
A clinical review of how cannabis (THC and CBD) interacts with finasteride pharmacokinetics, hormonal effects, and side-effect risk, with dosing guidance and physician sign-off.
A deep dive into the finasteride-nicotine interaction, covering pharmacokinetics, cardiovascular risk, sexual side-effect overlap, and practical guidance for men using nicotine products while on finasteride.
A comprehensive guide to finasteride's vaccine interaction profile, including immunologic mechanism, clinical evidence, alcohol considerations, and practical dosing guidance.
A clinician-level review of the finasteride and opioid interaction, covering CYP enzyme pathways, pharmacodynamic overlap, CNS/respiratory depression risk, monitoring parameters, and patient counseling points for oxycodone, hydrocodone, and tramadol.
Can you take finasteride with simvastatin? An evidence-based look at the CYP3A4 mechanism, what is established versus plausible, and what a clinician or pharmacist should verify before combining these drugs.
A clinician-level review of the flibanserin (Addyi) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein mechanisms, bleeding risk, severity classification, monitoring parameters, and patient counseling points.
A look at whether GHK-Cu (copper tripeptide) interacts with hormonal contraceptives, covering mechanism, copper physiology, CYP enzymes, and safe-use guidance.
A guide to the GHK-Cu and warfarin interaction, covering mechanism, INR monitoring, dose-adjustment principles, and patient counseling based on primary literature.
A guide to the pharmacodynamic interaction between insulin glargine (Lantus) and estradiol HRT, covering mechanism, blood glucose monitoring, dose adjustment, and patient counseling.
A clinical deep-dive into the pharmacodynamic and pharmacokinetic interaction between ipamorelin acetate and prednisone, covering mechanism, monitoring, dose considerations, and patient counseling.
An evidence-based review of the ipamorelin and trazodone combination, covering the sedation overlap between the two drugs, what is and is not established about growth hormone axis effects, and what to verify with a prescriber or pharmacist.
A comprehensive clinical guide to isotretinoin's anesthesia and perioperative interactions, covering airway dryness, hepatotoxicity overlap, bleeding risk, wound healing delay, and safe surgical timing.
A clinician-level review of the isotretinoin, apixaban drug interaction, covering CYP3A4/P-gp mechanisms, bleeding risk, monitoring parameters, and patient counseling backed by primary literature and FDA labeling.
A deep dive into the isotretinoin, clopidogrel drug interaction: CYP2C19 mechanism, clinical severity, monitoring parameters, dose considerations, and patient counseling points.
An evidence-status review of the isotretinoin and estradiol HRT combination, covering mechanism, triglyceride and VTE risk, monitoring, and what remains unverified.
A detailed clinical review of the isotretinoin and rosuvastatin drug interaction, covering mechanism, severity, monitoring parameters, dose adjustment, and patient counseling based on primary literature and FDA labeling.
Accutane and Zoloft have no pharmacokinetic interaction, so no dose change is needed, but isotretinoin's boxed mood warning calls for monthly PHQ-9 checks.
A guide to the isotretinoin and testosterone interaction, covering mechanism, polycythemia risk, lipid monitoring, dose considerations, and patient counseling for anyone on TRT or anabolic testosterone.
Can you take Jatenzo with ibuprofen or naproxen? A board-reviewed clinical breakdown of the GI, renal, cardiovascular, and bleeding risks when combining oral testosterone undecanoate with NSAIDs, with monitoring protocols and patient counseling points.
Everything you need to know about Dayvigo (lemborexant) and anesthesia interactions, including when to hold the dose, what to tell your anesthesiologist, and how alcohol fits into this picture.
A guide to the lemborexant, estradiol HRT drug interaction: CYP3A4 metabolism, pharmacodynamic overlap, VTE and CNS risk, dose guidance, and monitoring protocols.
A clinical deep-dive into the lemborexant (Dayvigo) and progesterone HRT drug interaction, covering CYP3A4 pharmacokinetics, additive sedation risk, dose-adjustment guidance, and patient counseling points.
A guide to the lemborexant, sildenafil drug interaction: CYP3A4 mechanism, hypotension risk, dose guidance, and monitoring for patients taking both Dayvigo and sildenafil.
A detailed clinical review of the levothyroxine, apixaban drug interaction: mechanism, severity, monitoring parameters, dose considerations, and patient counseling based on FDA labeling and primary literature.
Can you take Synthroid with ibuprofen or naproxen? Learn the clinical mechanisms, risk levels, monitoring parameters, and patient counseling points for the levothyroxine-NSAID interaction.
A guide to the levothyroxine-prednisone drug interaction: mechanism, clinical severity, TSH monitoring schedule, dose adjustment, and patient counseling points.
Estradiol HRT can raise thyroxine-binding globulin and blunt the effect of Tirosint (levothyroxine gel cap). Here is what is established, what is plausible but unproven, and what a clinician or pharmacist should verify before adjusting a dose.
A clinical deep-dive into the liraglutide and rivaroxaban drug interaction, covering mechanism, severity, monitoring parameters, dose considerations, and patient counseling points backed by primary literature.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between liraglutide and rosuvastatin, covering mechanism, severity, monitoring, dose adjustment, and patient counseling.
A clinical deep-dive into the liraglutide plus SSRI interaction: mechanism, serotonin syndrome risk, monitoring parameters, dose considerations, and patient counseling points backed by primary literature.
A guide to the liraglutide and tadalafil drug interaction, covering mechanism, blood pressure monitoring, dose adjustment, and patient counseling backed by primary literature.
A guide to the lisinopril and finasteride drug interaction: mechanism, severity, monitoring parameters, and patient counseling for safe co-administration.
A clinician-level review of the lisinopril and progesterone HRT interaction, covering mechanism, sedation overlap, blood pressure monitoring, and dose-adjustment guidance.
A detailed clinical guide to the lisinopril and testosterone interaction, covering mechanism, cardiovascular risk, polycythemia, blood pressure monitoring, and dose management for TRT patients.
A clinician-level review of the losartan and diphenhydramine drug interaction: pharmacokinetic and pharmacodynamic mechanisms, severity, monitoring, dose considerations, and patient counseling.
A guide to the losartan and finasteride drug interaction, covering mechanism, blood pressure effects, sexual side effects, monitoring protocols, and dose-adjustment strategies.
A clinical review of the losartan and progesterone HRT interaction, covering plausible mechanisms, what has and has not been directly studied, monitoring parameters, and patient counseling points, with an explicit map of evidence strength.
Can you drink alcohol on low-dose naltrexone? A guide covering pharmacology, safety data, timing rules, and clinical recommendations for LDN users.
A guide to the low-dose naltrexone and gabapentin drug interaction, covering pharmacokinetics, CNS sedation risk, renal considerations, and monitoring protocols.
LDN with levothyroxine: what the 898-person thyroid study found, how to schedule thyroid medication, and which test results should guide dose changes.
A guide to the pharmacodynamic and clinical interaction between low-dose naltrexone (LDN) and prednisone, including mechanism, severity, monitoring parameters, and patient counseling.
A clinical deep-dive into the pharmacokinetic and pharmacodynamic interaction between low-dose naltrexone (LDN) and rivaroxaban, including CYP3A4/P-gp mechanisms, bleeding risk, monitoring parameters, and patient counseling guidance.
A guide to the pharmacokinetic and clinical interaction between low-dose naltrexone (LDN) and simvastatin, covering CYP3A4 pathways, rhabdomyolysis risk, monitoring parameters, and dose-adjustment guidance.
A clinically detailed look at how alcohol interacts with metformin, covering lactic acidosis risk, hypoglycemia, liver metabolism, and practical drinking guidelines for people managing type 2 diabetes.
Everything patients and clinicians need to know about metformin's interaction with anesthesia, including when to hold the drug, lactic acidosis risk, contrast media timing, and post-op restart protocols.
A guide to the metformin-caffeine interaction profile, covering pharmacokinetics, blood glucose effects, lactic acidosis risk, and practical dosing guidance for patients on metformin who drink coffee, tea, or energy drinks.
A guide to the metformin and acetaminophen drug interaction, covering mechanism, safety evidence, dosing guidance, liver monitoring, and patient counseling for people with type 2 diabetes.